Parnasa: a blog project.
-

Stock Market Dynamics: The Role of Perception and Psychology
1. Behavioral Finance Theories Modern behavioral finance challenges the notion of fully rational investors by identifying recurring psychological biases that drive market behavior. Key theories include Prospect Theory, Herding Behavior, Loss Aversion, and Overconfidence Bias, each of which can significantly impact stock market movements. Prospect Theory Prospect Theory, developed by Daniel Kahneman and Amos Tversky,…
-

10 Undervalued U.S. Stocks with Strong Growth Potential (1–3 Year Horizon)
Investors seeking growth at a reasonable price can find opportunities in stocks that trade at low valuation multiples yet offer robust revenue and earnings growth prospects. Below are 10 U.S. companies – spanning technology, healthcare, consumer cyclical, and other sectors – that appear undervalued (e.g. low P/E and P/B ratios) while benefiting from strong financials,…
-

U.S.-Listed Robotics Stocks with Strong Growth Potential (2024-2025)
Robotics stocks stand at the intersection of technological innovation and market opportunity. Using key predictors – revenue growth, R&D investment, market trends alignment, and competitive positioning – we’ve identified established U.S.-listed robotics companies with high-risk, high-reward profiles likely to deliver strong performance in the next 1-3 years. We evaluated each company’s growth potential, risk/reward (volatility…
-

Probabilistic Outlook: Top U.S. Market Sectors for Next Year
Introduction Investors want to know which U.S. market sector is most likely to deliver the highest growth in the coming year. To answer this, we conducted a data-driven probabilistic analysis. We examined historical sector performance and a broad range of current factors – from economic indicators to technological trends – to estimate the likelihood that…
-

Top 7 Biotech Companies Poised for Success
Using the criteria of clinical success, financial stability, regulatory progress, market adoption potential, and long-term growth, the following seven biotech companies emerge as the most likely to succeed. Each has demonstrated notable strengths and a balance of near-term opportunities and transformative long-term potential, though each also faces challenges. Below is a detailed look at each…